1 |
250 mg ck-2017357 |
- |
- |
- |
- |
002 2件: 2 , 11 💬 |
2 |
3,4-dap |
- |
- |
- |
- |
011 1件: 11 💬 |
3 |
3,4-diaminopyridine |
- |
- |
- |
- |
011 3件: 11, 12, 13 💬 |
4 |
500 mg ck-2017357 |
- |
- |
- |
- |
002 2件: 2 , 11 💬 |
5 |
[acetominofene] |
- |
- |
- |
- |
011 1件: 11 💬 |
6 |
[m281] |
- |
- |
- |
- |
011 1件: 11 💬 |
7 |
[na] |
- |
- |
- |
- |
006 7件: 6 , 11, 35, 46, 53, 65, 299 💬 |
8 |
[tak-079, tsf-021, tsf79] |
- |
- |
- |
- |
011 1件: 11 💬 |
9 |
Abatacept |
Abatacept |
1件: D03203 D03203 💬 |
CD80 2件: CD80, CD86 💬 |
Allograft rejection 12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis |
011 26件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬 |
10 |
Abatacept injection |
Abatacept |
1件: D03203 D03203 💬 |
CD80 2件: CD80, CD86 💬 |
Allograft rejection 12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis |
011 2件: 11, 46 💬 |
11 |
Acetaminophen |
Acetaminophen |
1件: D00217 D00217 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
011 14件: 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬 |
12 |
Alxn1210 |
- |
- |
- |
- |
002 5件: 2 , 11, 13, 62, 109 💬 |
13 |
Amifampridina |
- |
- |
- |
- |
011 1件: 11 💬 |
14 |
Amifampridine |
Amifampridine |
1件: D10228 D10228 💬 |
KCNA4 4件: KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion 4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
003 3件: 3 , 11, 12 💬 |
15 |
Amifampridine phosphate |
Amifampridine |
1件: D10228 D10228 💬 |
KCNA4 4件: KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion 4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
003 3件: 3 , 11, 12 💬 |
16 |
Anti-c5 antibody |
- |
- |
- |
- |
011 4件: 11, 14, 62, 109 💬 |
17 |
Anti-thymocyte globulin |
- |
- |
- |
- |
011 18件: 11, 13, 14, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 164, 283, 284, 285 💬 |
18 |
Argx-113 |
- |
- |
- |
- |
011 4件: 11, 14, 35, 63 💬 |
19 |
Atg (rabbit) |
Rabbit |
- |
- |
- |
011 1件: 11 💬 |
20 |
Aza |
- |
- |
- |
- |
011 4件: 11, 40, 96, 97 💬 |
21 |
Azathioprine |
Azathioprine |
2件: D00238 D00238, D03033 D03033 💬 |
- |
- |
006 20件: 6 , 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 63, 65, 66, 85, 94, 95, 96, 97, 162 💬 |
22 |
B-peptide-crm197 conjugate |
- |
- |
- |
- |
011 1件: 11 💬 |
23 |
Bbr 2778 |
- |
- |
- |
- |
011 2件: 11, 13 💬 |
24 |
Belimumab |
Belimumab |
1件: D03068 D03068 💬 |
TNFSF13B 1件: TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
011 10件: 11, 43, 44, 46, 49, 51, 53, 66, 222, 300 💬 |
25 |
Benlysta (belimumab) |
Belimumab |
1件: D03068 D03068 💬 |
TNFSF13B 1件: TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
011 4件: 11, 49, 53, 222 💬 |
26 |
Benlysta® (belimumab) |
Belimumab |
1件: D03068 D03068 💬 |
TNFSF13B 1件: TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
011 3件: 11, 66, 222 💬 |
27 |
Bortezomib |
Bortezomib |
1件: D03150 D03150 💬 |
PSMB5 1件: PSMB5 💬 |
Alzheimer disease 8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia |
011 15件: 11, 13, 26, 28, 46, 49, 51, 61, 63, 66, 228, 256, 283, 288, 331 💬 |
28 |
Carmustine |
Carmustine |
1件: D00254 D00254 💬 |
- |
- |
011 5件: 11, 13, 14, 28, 60 💬 |
29 |
Cd19-directed humanised afucosylated monoclonal antibody |
- |
- |
- |
- |
011 1件: 11 💬 |
30 |
Cellcept |
- |
- |
- |
- |
011 5件: 11, 13, 42, 43, 49 💬 |
31 |
Cellcept 500 mg |
- |
- |
- |
- |
011 1件: 11 💬 |
32 |
Cellcept 500 mg film-coated tablets |
- |
- |
- |
- |
011 1件: 11 💬 |
33 |
Cellcept 500 mg tablets |
- |
- |
- |
- |
011 1件: 11 💬 |
34 |
Cellcept®500 mg tablets |
- |
- |
- |
- |
011 1件: 11 💬 |
35 |
Cfz533 |
- |
- |
- |
- |
011 4件: 11, 46, 49, 53 💬 |
36 |
Chloride |
Chloride ion |
- |
- |
- |
006 25件: 6 , 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 78, 96, 97, 127, 168, 171, 193, 227, 228, 271, 288, 296, 297, 299 💬 |
37 |
Cv-mg01 |
- |
- |
- |
- |
011 1件: 11 💬 |
38 |
Cyclophosphamide |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
011 44件: 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬 |
39 |
Cyclosporine |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
011 35件: 11, 19, 20, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 62, 63, 64, 65, 90, 95, 97, 162, 164, 222, 226, 228, 234, 283, 284, 285, 302 💬 |
40 |
Cytarabine |
Cytarabine |
3件: D00168 D00168, D03046 D03046, D03637 D03637 💬 |
- |
- |
011 6件: 11, 13, 14, 25, 49, 60 💬 |
41 |
Dap |
- |
- |
- |
- |
011 1件: 11 💬 |
42 |
Das-001 |
- |
- |
- |
- |
011 1件: 11 💬 |
43 |
Descartes-08 |
- |
- |
- |
- |
011 1件: 11 💬 |
44 |
Difenidramina |
- |
- |
- |
- |
011 1件: 11 💬 |
45 |
Difenidramina cloridrato |
- |
- |
- |
- |
011 1件: 11 💬 |
46 |
Diphenhydramine |
Diphenhydramine |
6件: D00300 D00300, D00669 D00669, D02419 D02419, D03285 D03285, D03360 D03360, D03854 D03854 💬 |
HRH1 1件: HRH1 💬 |
Calcium signaling pathway 3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
011 8件: 11, 49, 51, 70, 86, 96, 222, 256 💬 |
47 |
Diphenhydramine hydrochloride |
Diphenhydramine |
6件: D00300 D00300, D00669 D00669, D02419 D02419, D03285 D03285, D03360 D03360, D03854 D03854 💬 |
HRH1 1件: HRH1 💬 |
Calcium signaling pathway 3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
011 1件: 11 💬 |
48 |
Eculizumab |
Eculizumab |
1件: D03940 D03940 💬 |
C5 1件: C5 💬 |
Complement and coagulation cascades 9件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus |
011 8件: 11, 13, 14, 61, 62, 109, 222, 223 💬 |
49 |
Efalizumab |
Efalizumab |
1件: D03959 D03959 💬 |
ITGAL 1件: ITGAL 💬 |
Cell adhesion molecules 12件: Cell adhesion molecules, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Leukocyte transendothelial migration, Malaria, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, Viral myocarditis |
011 8件: 11, 13, 37, 46, 53, 61, 95, 96 💬 |
50 |
Efedrina |
Ephedrine |
1件: D00124 D00124 💬 |
ADRA1A 9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 |
AMPK signaling pathway 13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
011 1件: 11 💬 |
51 |
Efgartigimod |
- |
- |
- |
- |
011 3件: 11, 35, 63 💬 |
52 |
En101 |
- |
- |
- |
- |
011 1件: 11 💬 |
53 |
Ephedrine |
Ephedrine |
1件: D00124 D00124 💬 |
ADRA1A 9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 |
AMPK signaling pathway 13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
011 1件: 11 💬 |
54 |
Ephedrine hydrochloride |
Ephedrine |
1件: D00124 D00124 💬 |
ADRA1A 9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 |
AMPK signaling pathway 13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
011 1件: 11 💬 |
55 |
Etoposide |
Etoposide |
2件: D00125 D00125, D04107 D04107 💬 |
TOP2A 2件: TOP2A, TOP2B 💬 |
Platinum drug resistance 1件: Platinum drug resistance |
011 11件: 11, 13, 14, 26, 28, 34, 60, 65, 85, 164, 331 💬 |
56 |
Fc- and cdr-modified humanised monoclonal antibody against c5 |
- |
- |
- |
- |
011 3件: 11, 62, 109 💬 |
57 |
Firdapse |
- |
- |
- |
- |
011 1件: 11 💬 |
58 |
Firdapse - 10 mg - compresse - uso orale - blister(alu/pvc/pvdc) 100 x 1 compresse |
- |
- |
- |
- |
011 1件: 11 💬 |
59 |
Firdapse 10mg tablets |
- |
- |
- |
- |
011 1件: 11 💬 |
60 |
G-csf |
Filgrastim |
1件: D03235 D03235 💬 |
CSF3R 1件: CSF3R 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 16件: 2 , 6 , 11, 13, 16, 47, 49, 51, 60, 62, 65, 85, 96, 284, 285, 331 💬 |
61 |
Gamunex 10% |
- |
- |
- |
- |
011 1件: 11 💬 |
62 |
Gb-0998 (intravenous immunoglobulin) |
- |
- |
- |
- |
011 1件: 11 💬 |
63 |
Granulocyte-macrophage colony-stimulating factor (gm-csf) |
- |
- |
- |
- |
011 1件: 11 💬 |
64 |
Gsk1550188 |
- |
- |
- |
- |
011 4件: 11, 49, 66, 222 💬 |
65 |
Hbm9161 injection (340 mg) |
- |
- |
- |
- |
011 1件: 11 💬 |
66 |
Hbm9161 injection (680mg and 340 mg) |
- |
- |
- |
- |
011 1件: 11 💬 |
67 |
Hematopoietic stem cell transplantation |
- |
- |
- |
- |
011 12件: 11, 13, 14, 19, 20, 35, 46, 49, 51, 96, 234, 285 💬 |
68 |
Hidrocloruro de efedrina |
Ephedrine |
1件: D00124 D00124 💬 |
ADRA1A 9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 |
AMPK signaling pathway 13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
011 1件: 11 💬 |
69 |
Hizentra ® |
- |
- |
- |
- |
011 1件: 11 💬 |
70 |
Human normal immunoglobulin |
Human immunoglobulin G |
- |
- |
- |
011 9件: 11, 13, 14, 43, 45, 50, 51, 63, 65 💬 |
71 |
Human normal immunoglobulin (iv) |
Human immunoglobulin G |
- |
- |
- |
011 4件: 11, 14, 63, 65 💬 |
72 |
Human normal immunoglobulin g (igg) |
Human immunoglobulin G |
- |
- |
- |
011 1件: 11 💬 |
73 |
Igiv-c |
- |
- |
- |
- |
011 1件: 11 💬 |
74 |
Immune globulin |
- |
- |
- |
- |
011 3件: 11, 13, 14 💬 |
75 |
Immune globulin (human), 10% caprylate/chromatography purified |
- |
- |
- |
- |
011 1件: 11 💬 |
76 |
Immune globulin (human), 10% caprylate/chromatography purified (igiv-c) |
- |
- |
- |
- |
011 1件: 11 💬 |
77 |
Immunoglobulin g |
- |
- |
- |
- |
011 7件: 11, 13, 14, 49, 50, 63, 65 💬 |
78 |
Inebilizumab |
Inebilizumab |
1件: D11757 D11757 💬 |
CD19 1件: CD19 💬 |
B cell receptor signaling pathway 5件: B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency |
011 3件: 11, 13, 300 💬 |
79 |
Influenza vaccine |
- |
- |
- |
- |
011 5件: 11, 13, 46, 51, 84 💬 |
80 |
Intravenous immuneglobulin |
- |
- |
- |
- |
011 1件: 11 💬 |
81 |
Ivig |
- |
- |
- |
- |
011 8件: 11, 13, 14, 17, 35, 50, 51, 65 💬 |
82 |
Leflunomide |
Leflunomide |
1件: D00749 D00749 💬 |
DHODH 1件: DHODH 💬 |
Biosynthesis of cofactors 3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism |
011 10件: 11, 40, 46, 49, 53, 66, 162, 224, 271, 300 💬 |
83 |
M281 |
- |
- |
- |
- |
011 2件: 11, 61 💬 |
84 |
M281 injection |
- |
- |
- |
- |
011 1件: 11 💬 |
85 |
Mabthera |
- |
- |
- |
- |
011 22件: 11, 13, 14, 19, 35, 43, 44, 46, 49, 50, 51, 52, 53, 61, 63, 64, 65, 83, 93, 162, 222, 271 💬 |
86 |
Magnesium |
Magnesium |
- |
- |
- |
006 16件: 6 , 11, 13, 46, 64, 70, 93, 97, 166, 225, 235, 284, 291, 296, 297, 298 💬 |
87 |
Magnesium sulfate |
Magnesium |
1件: D01108 D01108 💬 |
- |
- |
011 3件: 11, 296, 297 💬 |
88 |
Melphalan |
Melphalan |
1件: D00369 D00369 💬 |
- |
- |
011 15件: 11, 13, 14, 19, 20, 28, 60, 62, 65, 96, 164, 234, 284, 285, 299 💬 |
89 |
Mesna |
- |
- |
- |
- |
011 11件: 11, 13, 44, 45, 49, 51, 60, 65, 85, 96, 164 💬 |
90 |
Mestinon |
- |
- |
- |
- |
003 3件: 3 , 6 , 11 💬 |
91 |
Methotrexate |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
011 35件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬 |
92 |
Methylprednisolone |
Methylprednisolone |
6件: D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
002 44件: 2 , 6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬 |
93 |
Metilprdnisolone |
- |
- |
- |
- |
011 1件: 11 💬 |
94 |
Metilprednisolone |
- |
- |
- |
- |
011 2件: 11, 53 💬 |
95 |
Monarsen |
- |
- |
- |
- |
011 1件: 11 💬 |
96 |
Monitor |
Methamidophos |
- |
- |
- |
002 18件: 2 , 11, 13, 19, 46, 49, 58, 65, 70, 85, 86, 98, 113, 118, 129, 298, 299, 300 💬 |
97 |
Mutagrip |
- |
- |
- |
- |
011 2件: 11, 13 💬 |
98 |
Mycophenolate |
Mycophenolic acid |
1件: D05096 D05096 💬 |
IMPDH1 2件: IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
002 34件: 2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬 |
99 |
Mycophenolate mofetil |
Mycophenolate mofetil |
4件: D00752 D00752, D05094 D05094, D05095 D05095, D05096 D05096 💬 |
IMPDH1 2件: IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
002 32件: 2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬 |
100 |
Mycophenolate mofetil (cellcept) |
Mycophenolate mofetil |
4件: D00752 D00752, D05094 D05094, D05095 D05095, D05096 D05096 💬 |
IMPDH1 2件: IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
011 2件: 11, 13 💬 |
101 |
Mycophenolate mofetil [cellcept] |
Mycophenolate mofetil |
4件: D00752 D00752, D05094 D05094, D05095 D05095, D05096 D05096 💬 |
IMPDH1 2件: IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
011 1件: 11 💬 |
102 |
Mycophenolic acid |
Mycophenolic acid |
1件: D05096 D05096 💬 |
IMPDH1 2件: IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
011 8件: 11, 43, 49, 51, 60, 66, 96, 222 💬 |
103 |
Other: laboratory biomarker analysis |
- |
- |
- |
- |
011 21件: 11, 13, 14, 16, 26, 28, 34, 49, 51, 60, 62, 65, 89, 96, 97, 232, 283, 284, 285, 298, 331 💬 |
104 |
Paracetamolo |
- |
- |
- |
- |
002 4件: 2 , 11, 14, 53 💬 |
105 |
Phosphate |
Phosphate ion |
- |
- |
- |
002 30件: 2 , 3 , 11, 12, 13, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 256, 276, 283, 284, 285, 286, 299 💬 |
106 |
Pixantrone |
Pixantrone |
1件: D05522 D05522 💬 |
TOP2A 2件: TOP2A, TOP2B 💬 |
Platinum drug resistance 1件: Platinum drug resistance |
011 2件: 11, 13 💬 |
107 |
Prednisolone |
Prednisolone |
8件: D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
011 40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬 |
108 |
Prednisone |
Prednisone |
1件: D00473 D00473 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
002 47件: 2 , 6 , 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 93, 95, 96, 97, 113, 127, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 💬 |
109 |
Prednisone - azathioprine |
Azathioprine |
3件: D00238 D00238, D00473 D00473, D03033 D03033 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
011 1件: 11 💬 |
110 |
Prednisone alone |
Prednisone |
1件: D00473 D00473 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
011 2件: 11, 66 💬 |
111 |
Privigen |
- |
- |
- |
- |
011 4件: 11, 14, 51, 65 💬 |
112 |
Procedure: autologous hematopoietic stem cell transplantation |
- |
- |
- |
- |
011 6件: 11, 13, 14, 28, 49, 51 💬 |
113 |
Procedure: peripheral blood stem cell transplantation |
- |
- |
- |
- |
011 11件: 11, 13, 14, 28, 51, 60, 62, 65, 283, 284, 285 💬 |
114 |
Procedure: plasmapheresis |
- |
- |
- |
- |
011 3件: 11, 49, 222 💬 |
115 |
Procedure: plex |
- |
- |
- |
- |
011 1件: 11 💬 |
116 |
Procedure: syngeneic bone marrow transplantation |
- |
- |
- |
- |
011 3件: 11, 13, 14 💬 |
117 |
Procedure: thymectomy plus prednisone |
Prednisone |
1件: D00473 D00473 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
011 1件: 11 💬 |
118 |
Pyridostigmine |
Pyridostigmine |
1件: D00487 D00487 💬 |
ACHE 1件: ACHE 💬 |
Cholinergic synapse 2件: Cholinergic synapse, Glycerophospholipid metabolism |
003 4件: 3 , 6 , 11, 256 💬 |
119 |
Rabbit |
Rabbit |
- |
- |
- |
011 8件: 11, 13, 49, 51, 60, 65, 96, 285 💬 |
120 |
Raptiva |
- |
- |
- |
- |
011 9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 💬 |
121 |
Raptiva 100 mg/ml powder and solvent for solution for injection |
- |
- |
- |
- |
011 7件: 11, 13, 46, 53, 61, 95, 96 💬 |
122 |
Ravulizumab |
Ravulizumab |
1件: D11054 D11054 💬 |
C5 1件: C5 💬 |
Complement and coagulation cascades 9件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus |
002 5件: 2 , 11, 13, 62, 109 💬 |
123 |
Rc18 160mg |
- |
- |
- |
- |
011 3件: 11, 13, 66 💬 |
124 |
Rc18 240 mg |
- |
- |
- |
- |
011 2件: 11, 53 💬 |
125 |
Rituximab |
Rituximab |
1件: D02994 D02994 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
011 47件: 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬 |
126 |
Rituximab (rituxan) |
Rituximab |
1件: D02994 D02994 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
011 1件: 11 💬 |
127 |
Rozanolixizumab |
Rozanolixizumab |
- |
- |
- |
011 3件: 11, 14, 63 💬 |
128 |
Rtx |
- |
- |
- |
- |
011 4件: 11, 65, 222, 240 💬 |
129 |
Rvt-1401 |
- |
- |
- |
- |
011 2件: 11, 61 💬 |
130 |
Salbutamol |
Salbutamol |
1件: D02147 D02147 💬 |
ADRB2 1件: ADRB2 💬 |
Adrenergic signaling in cardiomyocytes 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
003 9件: 3 , 11, 49, 85, 86, 111, 228, 256, 299 💬 |
131 |
Salbutamol 4mg tablet |
Salbutamol |
1件: D02147 D02147 💬 |
ADRB2 1件: ADRB2 💬 |
Adrenergic signaling in cardiomyocytes 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
011 1件: 11 💬 |
132 |
Salbutamol sulfate ph. eur. |
Salbutamol |
1件: D02147 D02147 💬 |
ADRB2 1件: ADRB2 💬 |
Adrenergic signaling in cardiomyocytes 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
011 1件: 11 💬 |
133 |
Salbutamol wzf 4 mg |
Salbutamol |
1件: D02147 D02147 💬 |
ADRB2 1件: ADRB2 💬 |
Adrenergic signaling in cardiomyocytes 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
011 1件: 11 💬 |
134 |
Sodium chloride |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
006 20件: 6 , 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 78, 96, 168, 193, 227, 228, 271, 288, 299 💬 |
135 |
Sodium chloride solution |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
011 3件: 11, 13, 228 💬 |
136 |
Soliris |
- |
- |
- |
- |
011 7件: 11, 13, 14, 61, 62, 109, 222 💬 |
137 |
Subcutaneous immunoglobulins |
- |
- |
- |
- |
011 1件: 11 💬 |
138 |
Sulfate |
Sulfate ion |
- |
- |
- |
002 25件: 2 , 6 , 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 79, 85, 86, 96, 111, 222, 226, 265, 296, 297, 299 💬 |
139 |
Symptomatic treatment, steroids, immunosuppressive agents( azathioprine, tacrolimus, mycophenolate mofetil) |
Azathioprine |
8件: D00107 D00107, D00238 D00238, D00752 D00752, D03033 D03033, D05094 D05094, D05095 D05095, D05096 D05096, D08556 D08556 💬 |
IMPDH1 7件: IMPDH1, IMPDH2, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 35件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Drug metabolism - other enzymes, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Purine metabolism, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
011 1件: 11 💬 |
140 |
Symptomatic treatment, steroids, immunosuppressive agents, plasma exchange(pe), intravenous immunoglobulin(ivig) |
Human immunoglobulin G |
- |
- |
- |
011 1件: 11 💬 |
141 |
T-peptide-crm197 conjugate |
- |
- |
- |
- |
011 1件: 11 💬 |
142 |
Tacrolimus |
Tacrolimus |
2件: D00107 D00107, D08556 D08556 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
002 32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬 |
143 |
Tacrolimus capsule |
Tacrolimus |
2件: D00107 D00107, D08556 D08556 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
011 1件: 11 💬 |
144 |
Tak-079 |
- |
- |
- |
- |
011 3件: 11, 49, 63 💬 |
145 |
Tetanus vaccin |
- |
- |
- |
- |
011 1件: 11 💬 |
146 |
Tofacitinib |
Tofacitinib |
1件: D09970 D09970 💬 |
JAK1 4件: JAK1, JAK2, JAK3, TYK2 💬 |
AGE-RAGE signaling pathway in diabetic complications 35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
011 12件: 11, 40, 46, 49, 50, 51, 53, 84, 96, 97, 107, 271 💬 |
147 |
Tofacitinib 5 mg |
Tofacitinib |
1件: D09970 D09970 💬 |
JAK1 4件: JAK1, JAK2, JAK3, TYK2 💬 |
AGE-RAGE signaling pathway in diabetic complications 35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
011 3件: 11, 46, 271 💬 |
148 |
Ucb7665 |
- |
- |
- |
- |
011 3件: 11, 14, 63 💬 |
149 |
Ultomiris |
- |
- |
- |
- |
002 4件: 2 , 11, 13, 62 💬 |
150 |
Velcade |
- |
- |
- |
- |
011 5件: 11, 28, 46, 49, 61 💬 |
151 |
Velcade® |
- |
- |
- |
- |
011 3件: 11, 46, 49 💬 |
152 |
Zilucoplan |
Zilucoplan |
- |
- |
- |
002 3件: 2 , 11, 62 💬 |
153 |
Zilucoplan (ra101495) |
Zilucoplan |
- |
- |
- |
011 2件: 11, 62 💬 |